Sri Lanka

The National Medicines Regulatory Authority (NMRA), established under the National Medicines Regulatory Authority Act No. 5 of 2015, serves as Sri Lanka's primary regulatory body for health products, including pharmaceuticals, medical devices, diagnostics, and increasingly digital health solutions. The NMRA is responsible for the registration, licensing, post-market surveillance, and quality control of all health products entering or manufactured within the country. The general approval process requires applicants to submit a formal registration dossier, undergo technical evaluation by NMRA expert committees, and receive a Certificate of Registration before any product may be legally marketed. Products are classified by risk level, with higher-risk items subject to more stringent review pathways, and all registered products must be renewed periodically to maintain market authorization.

Submission requirements mandate that applicants appoint a locally registered entity or authorized representative in Sri Lanka to liaise with the NMRA and bear regulatory responsibility. Dossiers are generally accepted in the ASEAN Common Technical Dossier (ACTD) format, though the ICH Common Technical Document (CTD) format is also recognized, particularly for products already approved in stringent regulatory authority (SRA) jurisdictions such as the US FDA, EMA, TGA, or Health Canada. The NMRA has progressively introduced reforms aimed at streamlining registration timelines, including abridged and verification review pathways for products holding SRA approvals, which can significantly reduce review periods. Recent regulatory modernization efforts have also focused on strengthening post-market surveillance frameworks, developing guidance for medical devices and in-vitro diagnostics, and building capacity for the oversight of digital health technologies, aligning Sri Lanka more closely with international regulatory best practices.

Public procurement of health products in Sri Lanka is centrally coordinated through the Ministry of Health, with the State Pharmaceuticals Corporation (SPC) and the State Pharmaceuticals Manufacturing Corporation (SPMC) playing pivotal roles in the procurement and distribution of medicines and medical supplies to the public health system. The Medical Supplies Division (MSD) of the Ministry of Health manages the quantification, tendering, and distribution of essential medicines, medical devices, and diagnostics to government hospitals and health facilities nationwide. Procurement is conducted through a national tender process governed by the National Procurement Guidelines, with the National Medicines Regulatory Authority registration being a prerequisite for participation. Sri Lanka maintains a National Essential Medicines List (NEML) that heavily guides public procurement priorities, and suppliers must demonstrate product quality, registration compliance, and competitive pricing to secure government contracts.

The private sector constitutes a significant parallel channel for health product procurement in Sri Lanka, served by a network of private importers, distributors, and retail pharmacies operating under NMRA licensing. Multinational companies and local distributors engage directly with private hospitals, clinic chains, and pharmacy groups, where market access is driven by clinical preference, brand recognition, and commercial negotiation rather than centralized tender. Donor-funded procurement also plays a meaningful role, particularly in disease-specific programs: organizations such as UNICEF, the Global Fund, and the World Health Organization have historically supported procurement of commodities for HIV, tuberculosis, malaria, and immunization programs, often channeled through government systems with NMRA oversight. Sri Lanka has an established domestic pharmaceutical manufacturing sector, and government procurement policies reflect a preference for locally manufactured or regionally sourced products where quality and supply assurance can be demonstrated, with SPC and SPMC acting as key domestic production and procurement anchors.